BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2256 related articles for article (PubMed ID: 3495737)

  • 1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
    Förstermann U
    Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.
    Dusting GJ; Read MA; Stewart AG
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of EDRF and nitric oxide on vascular strips.
    Hutchinson PJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1987 Sep; 141(3):445-51. PubMed ID: 3499329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular reactivity to endothelium-derived relaxing factor in human umbilical artery at term pregnancy.
    Sugawara M; Tohse N; Nagashima M; Yabu H; Kudo R
    Can J Physiol Pharmacol; 1997 Jul; 75(7):818-24. PubMed ID: 9315349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
    Gräser T; Vedernikov YP
    Biomed Biochim Acta; 1989; 48(4):351-3. PubMed ID: 2787633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of doxazosin on the activity of the endothelium-derived relaxing factor.
    Yeates RA
    Arzneimittelforschung; 1994 Oct; 44(10):1117-21. PubMed ID: 7818583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do enflurane and isoflurane interfere with the release, action, or stability of endothelium-derived relaxing factors?
    Blaise G; Guy C; To Q; Sauvé R
    Can J Anaesth; 1997 May; 44(5 Pt 1):550-8. PubMed ID: 9161752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta.
    Andrews HE; Bruckdorfer KR; Dunn RC; Jacobs M
    Nature; 1987 May 21-27; 327(6119):237-9. PubMed ID: 3106833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to EDRF research.
    Furchgott RF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.
    Tracey WR; Linden J; Peach MJ; Johns RA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):922-8. PubMed ID: 2319475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the potencies of EDRF-releasers from isolated rabbit aortic strips.
    Trybulec M; Dudek R; Radziszewski W; Swierkosz T; Zembowicz A
    Acta Physiol Pol; 1990; 41(1-3):79-86. PubMed ID: 1669477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 113.